1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Hepáticas y Digestivas

Enfermedades Hepáticas y Digestivas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Agudo-Quílez P, Martín-Moro F, Antoñana Ugalde S, Blanco-Peláez E, García-Cosío M, Tenelanda A, Lledó Navarro JL, López-Jiménez J, Zamorano Gómez JL.

    Primary Cardiac Aggressive B-Cell Lymphoma Affecting Right Ventricle and Acute Cardiovascular Events: Multidisciplinary Approach.

    Jacc. Case Reports . 29(19): 102562-102562.

    [doi:10.1016/j.jaccas.2024.102562]

  • Albillos A, Bañares R, Hernández-Gea V.

    Portal hypertension: recommendations for diagnosis and treatment. Consensus document sponsored by the Spanish Association for the Study of the Liver (AEEH) and the Biomedical Research Network Center for Liver and Digestive Diseases (CIBERehd).

    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS . : .

    [doi:10.17235/reed.2024.10805/2024]

  • Olivas P, Soler-Perromat A, Tellez L, Carrión JA, Alvarado-Tapias E, Ferrusquía-Acosta J, Lens S, Guerrero A, Falgà Á, Vizcarra P, Orts L, Perez-Campuzano V, Shalaby S, Torres S, Baiges A, Turon F, García-Pagán JC, García-Criado Á, Hernández-Gea V.

    Persistent varices in cured patients: Understanding the role of hepatic venous pressure gradient.

    JHEP REPORTS . 6(10): 101170-101170.

    [doi:10.1016/j.jhepr.2024.101170]

  • Dajti E, Villanueva C, Berzigotti A, Brujats A, Albillos A, Genescà J, Garcia-Pagán JC, Colecchia A, Bosch J.

    Exploring algorithms to select candidates for non-selective beta-blockers in cirrhosis: a post-hoc analysis of the PREDESCI trial.

    JOURNAL OF HEPATOLOGY . : .

    [doi:10.1016/j.jhep.2024.09.014]

  • Téllez L, Rincón D, Payancé A, Jaillais A, Lebray P, Rodríguez de Santiago E, Clemente A, Paradis V, Lefort B, Garrido-Lestache E, Prieto R, Iserin L, Tallegas M, Garrido E, Torres M, Muriel A, Perna C, Jesús Del Cerro M, d'Alteroche L, Rautou PE, Bañares R, Albillos A.

    Non-invasive assessment of severe liver fibrosis in patients with Fontan-associated liver disease: The VALDIG-EASL FONLIVER cohort.

    JOURNAL OF HEPATOLOGY . : .

    [doi:10.1016/j.jhep.2024.09.005]

  • Iborra M, Caballol B, Garrido A, Huguet JM, Mesonero F, Ponferrada Á, Arias García L, Boscá Watts MM, Fernández Prada SJ, Brunet Mas E, Gutiérrez Casbas A, Cerrillo E, Ordás I, Ruiz L, García de la Filia I, Escobar Ortiz J, Sicilia B, Ricart E, Domènech E, Nos P.

    Subcutaneous infliximab cut-off points in patients with inflammatory bowel disease. Data from the ENEIDA registry.

    JOURNAL OF CROHNS & COLITIS . : . Nº de citas: 1

    [doi:10.1093/ecco-jcc/jjae127]

  • Iruzubieta P, Mayo R, Mincholé I, Martínez-Arranz I, Arias-Loste MT, Ibañez-Samaniego L, Ampuero J, Abad J, Martín-Mateos R, Fernández-Laso AB, Albillos A, Bañares R, Calleja JL, Romero-Gómez M, Aller R, Crespo J.

    One-step non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis and fibrosis in high-risk population.

    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL . 12(7): 919-929.

    [doi:10.1002/ueg2.12589]

  • Elkrief L, Hernandez-Gea V, Senzolo M, Albillos A, Baiges A, Berzigotti A, Bureau C, Murad SD, De Gottardi A, Durand F, Garcia-Pagan JC, Lisman T, Mandorfer M, McLin V, Moga L, Nery F, Northup P, Nuzzo A, Paradis V, Patch D, Payancé A, Plaforet V, Plessier A, Poisson J, Roberts L, Salem R, Sarin S, Shukla A, Toso C, Tripathi D, Valla D, Ronot M, Rautou PE.

    Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies.

    LANCET GASTROENTEROLOGY & HEPATOLOGY . 9(9): 859-883. Nº de citas: 3

    [doi:10.1016/S2468-1253(24)00155-9]

  • Simón AM, de Leyva P, Cárdenas C, Vieira N, García M, Ranz Á, Bueno Á, Nuñez J, Almeida F, Picón M, Acero J.

    Carcinoma Cuniculatum, a Rare Variant of Oral Squamous Cell Carcinoma: Presentation of Five Clinical Cases and Review of the Literature.

    JOURNAL OF MAXILLOFACIAL & ORAL SURGERY . 23(4): 972-978.

    [doi:10.1007/s12663-024-02247-9]

  • Rodríguez-Perálvarez ML, de la Rosa G, Gómez-Orellana AM, Aguilera MV, Pascual Vicente T, Pereira S, Ortiz ML, Pagano G, Suarez F, González Grande R, Cachero A, Tomé S, Barreales M, Martín Mateos R, Pascual S, Romero M, Bilbao I, Alonso Martín C, Otón E, González Diéguez L, Espinosa MD, Arias Milla A, Blanco Fernández G, Lorente S, Cuadrado Lavín A, Redín García A, Sánchez Cano C, Cepeda-Franco C, Pons JA, Colmenero J, Guijo-Rubio D, Otero A, Amador Navarrete A, Romero Moreno S, Rodríguez Soler M, Hervás Martínez C, Gastaca M.

    GEMA-Na and MELD 3.0 severity scores to address sex disparities for accessing liver transplantation: a nationwide retrospective cohort study.

    Eclinicalmedicine . 74: 102737-102737. Nº de citas: 1

    [doi:10.1016/j.eclinm.2024.102737]

  • Calafat M, Suria C, Mesonero F, de Francisco R, Caballero CY, Peña L, Hernández-Camba A, Marcé A, Gallego B, Martín-Vicente N, Rivero M, Iborra M, Guerra I, Carrillo-Palau M, Madero L, Burgueño B, Monfort D, Torres G, Teller M, Ferrer Rosique JÁ, Villaamil PV, Roig C, Ponferrada-Diaz A, Glaría EB, Zabana Y, Gisbert JP, Busquets D, Alcaide N, Camps B, Legido J, González-Vivo M, Bosca-Watts MM, Pérez-Martínez I, Deza DC, Guardiola J, Hernández LA, Navarro M, Gargallo-Puyuelo CJ, Cañete F, Mañosa M, Domènech E.

    HIV infection is associated with a less aggressive phenotype of inflammatory bowel disease. A multicenter study of the ENEIDA registry.

    The American journal of gastroenterology . 120(2): 431-439.

    [doi:10.14309/ajg.0000000000002965]

  • Ampuero J, Aller R, Gallego-Durán R, Crespo J, Calleja JL, García-Monzón C, Gómez-Camarero J, Caballería J, Lo Iacono O, Ibañez L, García-Samaniego J, Albillos A, Francés R, Fernández-Rodríguez C, Maya-Miles D, Diago M, Poca M, Andrade RJ, Latorre R, Jorquera F, Morillas RM, Escudero D, Hernández-Guerra M, Pareja-Megia MJ, Banales JM, Aspichueta P, Benlloch S, Rosales JM, Turnes J, Romero-Gómez M.

    The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis.

    JOURNAL OF GASTROENTEROLOGY . 59(7): 586-597.

    [doi:10.1007/s00535-024-02098-8]

  • Boos J, van der Made CI, Ramakrishnan G, Coughlan E, Asselta R, Löscher BS, Valenti LVC, de Cid R, Bujanda L, Julià A, Pairo-Castineira E, Baillie JK, May S, Zametica B, Heggemann J, Albillos A, Banales JM, Barretina J, Blay N, Bonfanti P, Buti M, Fernandez J, Marsal S, Prati D, Ronzoni L, Sacchi N, Schultze JL, Riess O, Franke A, Rawlik K, Ellinghaus D, Hoischen A, Schmidt A, Ludwig KU.

    Stratified analyses refine association between TLR7 rare variants and severe COVID-19.

    HUMAN GENETICS AND GENOMICS ADVANCES . 5(4): 100323-100323. Nº de citas: 1

    [doi:10.1016/j.xhgg.2024.100323]

  • Pioche M, Cunha Neves JA, Pohl H, Quyen M, Grau R, Dray X, Yzet C, Mochet M, Jacques J, Wallenhorst T, Rivory J, Siret N, Peillet AL, Chevaux JB, Mion F, Chaput U, Jacob P, Grinberg D, Saurin JC, Baddeley R, Rodriguez de Santiago E, Cottinet PJ.

    Environmental impact of small-bowel capsule endoscopy.

    Endoscopy . 56(10): 737-746. Nº de citas: 3

    [doi:10.1055/a-2313-5142]

  • Liu J, MacNaughtan J, Kerbert AJC, Portlock T, Martínez Gonzalez J, Jin Y, Clasen F, Habtesion A, Ji H, Jin Q, Phillips A, De Chiara F, Ingavle G, Jimenez C, Zaccherini G, Husi K, Rodriguez Gandia MA, Cordero P, Soeda J, McConaghy L, Oben J, Church K, Li JV, Wu H, Jalan A, Gines P, Solà E, Eaton S, Morgan C, Kowalski M, Green D, Gander A, Edwards LA, Cox IJ, Cortez-Pinto H, Avery T, Wiest R, Durand F, Caraceni P, Elosua R, Vila J, Pavesi M, Arroyo V, Davies N, Mookerjee RP, Vargas V, Sandeman S, Mehta G, Shoaie S, Marchesi J, Albillos A, Andreola F, Jalan R.

    Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbable, gut-restricted adsorbent in models and patients with cirrhosis.

    Gut . 73(7): 1183-1198.

    [doi:10.1136/gutjnl-2023-330699]

  • Casanova MJ, Caballol B, García MJ, Mesonero F, Rubín de Célix C, Suárez-Álvarez P, Ferreiro-Iglesias R, Martín-Rodríguez MDM, de Francisco R, Varela-Trastoy P, Bastida G, Carrillo-Palau M, Núñez-Ortiz A, Ramírez-de la Piscina P, Ceballos D, Hervías-Cruz D, Muñoz-Pérez R, Velayos B, Bermejo F, Busquets D, Cabacino M, Camo-Monterde P, Marín-Jiménez I, Muñoz C, de la Peña-Negro LC, Sierra-Moros E, Barrio J, Brunet-Mas E, Bujanda L, Cañete F, Gomollón F, Manceñido-Marcos N, Rodríguez-Lago I, Rodríguez-Grau MC, Sicilia B, Torra-Alsina S, Arranz-Hernández L, Carpio D, García-Sepulcre MF, González-Muñoza C, Huguet JM, Márquez-Mosquera L, López-Serrano MP, Ponferrada-Díaz Á, Chaparro M, Gisbert JP.

    Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU.

    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver . 56(11): 1845-1853.

    [doi:10.1016/j.dld.2024.05.009]

  • Albillos A, Carballo F, Crespo J.

    Strategic analysis and recommendations of the Sociedad Española de Patología Digestiva (SEPD) regarding population-based screening programs for colorectal cancer in Spain.

    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS . 116(6): 319-329.

    [doi:10.17235/reed.2024.10458/2024]

  • Ferreiro-Iglesias R, Porto Silva S, Marín S, Casanova MJ, Mañosa M, González-Muñoza C, de Francisco R, Caballol B, Arias L, Piqueras M, Zabana Y, Rivero M, Calvet X, Mesonero F, Varela Trastoy P, Busta Nistal R, Gómez Perosanz R, Vega P, Gonzalez-Vivo M, Iborra M, Bermejo F, Madero L, Rodríguez-Lago I, Rodríguez Gonzalez M, Vera I, Ponferrada Díaz Á, Vela M, Torrealba Medina L, Van Domselaar M, Gomollón F, Iglesias E, Gisbert JP, Calafat M, Giordano A, Pérez-Martínez I, Ricart E, Sicilia B, Mena R, Esteve M, Rivas C, Brunet-Mas E, FERNÁNDEZ FERNÁNDEZ, CRISTINA, de Jorge Turrión MÁ, Velayos Jiménez B, Quiñones Calvo M, Regueiro Expósito C, Márquez-Mosquera L, Nos P, Granja A, Gutiérrez A, Cabriada JL, Hervías Cruz D, Calvo M, Pérez Pérez J, Rodríguez Díaz Y, Busquets Casal D, Menacho M, Leal C, Lucendo AJ, Royo V, Olivares S, Álvarez Herrero B, Carrillo-Palau M, Gilabert Álvarez P, Manceñido Marcos N, Martínez-Pérez TJ, Muñoz Villafranca MC, Almela P, Argüelles-Arias F, Legido J, Fuentes Coronel AM, Nieto L, Domènech E, Barreiro-de Acosta M.

    Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry.

    ALIMENTARY PHARMACOLOGY & THERAPEUTICS . 60(5): 604-612.

    [doi:10.1111/apt.18133]